Celldex Therapeutics (CLDX) traded up 0.97 % during a 24 hours period ending at 12:26 AM Central Europe on Tuesday 27th. One Celldex Therapeutics stock can currently be bought for about USD 29.5 on popular exchanges. Current supply of Celldex Therapeutics stocks is 78.6 mn. Celldex Therapeutics has a current market capitalization of USD 2.3 bn and approximately USD 25.7 mn worth of Celldex Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Celldex Therapeutics has traded -7.08 % down. Simple moving average of last 200 days is at USD 32.56. The highest price of past 52 weeks was recorded at USD 45.14 on 08/12/2026. 52 weeks low was at USD 22.1 on 11/11/2025.

Here is how related stocks have performed in the past 24 hours:

  • Tootsie Roll Inds (TR) traded down -6.48 % and now trades at USD 34.54. Tootsie Roll Inds has a market capitalisation of USD 2.7 bn. Tootsie Roll Inds has a current price to earnings ratio of 27.36.

  • Wiley & Sons (WLY) traded down -0.26 % and now trades at USD 53.63. Current market capitalisation for Wiley & Sons is USD 2.7 bn. Current price/earnings ratio for Wiley & Sons is 14.33.

  • Knowles (KN) traded down -3.62 % and now trades at USD 32.65. Knowles has a market capitalisation of USD 2.7 bn. Knowles has a current price to earnings ratio of 38.92.

  • Ethos Cl (LIFE) traded down -0.99 % and now trades at USD 42.3. Ethos Cl has a market capitalisation of USD 2.8 bn.

  • Penguin (PENG) traded up 2.89 % and now trades at USD 54.92. Current market capitalisation for Penguin is USD 2.7 bn. Penguin has a current price to earnings ratio of 20.8.

About Celldex Therapeutics

Celldex Therapeutics Inc. is a biopharmaceutical company that uses immunological applications to prevent and treat various diseases. The company’s products address autoimmune diseases, cardiovascular issues, cancer, inflammation, as well as infectious diseases and organ transplant rejection. Their Webseite is www.celldex.com , and they are listed on the Nasdaq stock exchange. Their Initial Public Offering (IPO) date was March 10, 2008.